Adel Hamed ELBAİH1, Ahmed G. ELSAYED, Gamela M. NASR, Mona M. RAYAN

Cardiogenic shock as a first presentation in acute myocardial infarction in Egyptian’s patients and its outcome

Cardiogenic shock secondary to acute myocardial infarction continues to be a frustrating problem of great clinical significance. With improvements in the medical management of AMI, particularly the treatment of ventricular arrhythmias, CS has emerged as the most common cause of death (7 to 12%) of all patients admitted with myocardial infarction. Was to minimise the impact of acute MI and/or its complications especially cardiogenic shock by early detection and rapid diagnosis to improve management processes. The study was descriptive, comprehensive study that included 60 patients presented with acute myocardial infarction with or without cardiogenic shock. Firstly assessed clinical, Electrocardiography and cardiac enzymes with treatment accordingly to Advanced Cardiac Life Support (ACLS) guidelines and treat the life threading conditions if present with follow-up throughout their hospital stays for Major Adverse Cardiac Events (MACE) that included death, reinfarction. The incidence of cardiogenic shock as the presenting problem in acute MI was 13.3%. The Patients with cardiogenic shock stayed more in the hospital with significantly more incidence of reinfarction and in-hospital mortality. Cases with CS were older in age, had a higher incidence of diabetes mellitus, angina, previous MI and heart failure, a larger size of infarction, as reflected in increased level of cardiac enzymes, and was found in patients with CS.

PDF

___

Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H. Current spectrum of cardiogenic shock and effect of early revascularisation on mortality. Results of an international registry. SHOCK registry investigators. Circulation. 1995;91(3):873-81.

Giannuzzi P, Imparato A, Temporelli PL, de Vito F, Silva PL, Scapellato F, Giordano A. Doppler derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in post-infarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 1994;23(7):1630-7.

Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy; a systemic review. Eur Heart J. 2006;27(13):1523-9.

Steg PG1, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P; Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolyis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2203;108(23):2851-6.

Lindholm MG1, Køber L, Boesgaard S, Torp-Pedersen C, Aldershvile J; Trandolapril Cardiac Evaluation study group. Cardiogenic shock complicating acute myocardial infarction: prognostic impact of early and late shock development. Eur Heart J. 2003;24(3):258-65.

Rao SV1, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(10):1193-204.

Stramba-Badiale M1, Fox KM, Priori SG, Collins P, Daly C, Graham I, Jonsson B, Schenck-Gustafsson K, Tendera M. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J. 2006;27(8):995-1005.

Thygesen K1, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525-38.

Guo L1, Mai X, Deng J, Liu A, Bu L, Wang H. Early percutaneous intervention improves survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Kardiol Pol. 2008;66(7):722-6.

Braždžionytė J, Macas A. Impedance cardiography of aortic balloon counterpulsation impact assessment on patient’s hemodynamics during acute myocardial infarction. Medicina (Kaunas). 2006;42(11):904-13.

Van de Werf F1, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M; ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909-45.

Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598-660.

Fang J, Mensah GA, Alderman MH, Croft JB. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. Am Heart J. 2006;152(6):1035-41.

Goldberg RJ, Spencer FA, Gore GM, Lessard D. Thirty Year Trends (19752005) in the Magnitude, Management, and Hospital Death Rates Associated With Cardiogenic Shock in Patients with Acute Myocardial Infarction: A Population-Based Perspective. Circulation. 2009;10;119(9):1211-9

Hameed AK1, Gosal T, Fang T, Ahmadie R, Lytwyn M, Barac I, Zieroth S, Hussain F, Jassal DS. Clinical utility of tissue Doppler imaging in patients with acute myocardial infarction complicated by cardiogenic shock. Cardiovascular Ultrasound. 2008;6:11.

Nicholls SJ1, Wang Z, Koeth R, Levison B, DelFraino B, Dzavik V, Griffith OW, Hathaway D, Panza JA, Nissen SE, Hochman JS, Hazen SL. Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients with Cardiogenic Shock after Acute Myocardial Infarction. Circulation. 2007;116(20):2315-24.

Sanborn TA1, Sleeper LA, Webb JG, French JK, Bergman G, Parikh M, Wong SC, Boland J, Pfisterer M, Slater JN, Sharma S, Hochman JS; SHOCK Investigators. Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol. 2003;42(8):1373-9.

Webb JG1, Sleeper LA, Buller CE, Boland J, Palazzo A, Buller E, White HD, Hochman JS. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol. 2000;36(3 Suppl A):1084-90.

Picard MH1, Davidoff R, Sleeper LA, Mendes LA, Thompson CR, Dzavik V, Steingart R, Gin K, White HD, Hochman JS; SHOCK Trial. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation. 2003;107(2):279-84.

Elbaih AH, Aza ZA, Elsakaya M, Awer A. Assessment of management of acute coronary syndrome in the emergency department Suez Canal University hospital. Applied Medical Research Journal. 2016;2(2);35-40.